Philip Morris International (PMI) supports effective evidence-based regulation of tobacco products based on the principle of harm reduction.
Learn more about our regulatory approach here.
We aim to reduce the harm caused by smoking by supporting effective evidence-based regulation of tobacco products and through our investment in developing products with the potential to reduce the risk of tobacco-related disease. Regulations can encourage harm reduction by providing frameworks and guidelines for the development and assessment of products that have the potential to reduce the risk of diseases caused by conventional cigarettes.
Learn more about harm reduction.
Smoking causes many serious diseases including cardiovascular disease, lung cancer and chronic obstructive pulmonary disease. Smoking is also addictive and can be extremely difficult to quit.
Learn more about the health effects of smoking.